Tocilizumab for the treatment of severe coronavirus disease 2019
…, S Abdalla, K Shukri, JN Daghfal… - Journal of medical …, 2020 - Wiley Online Library
Tocilizumab, an interleukin‐6 inhibitor, may ameliorate the inflammatory manifestations
associated with severe coronavirus disease 2019 (COVID‐19) and thus improve clinical …
associated with severe coronavirus disease 2019 (COVID‐19) and thus improve clinical …
[HTML][HTML] Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19
…, R Al Kahlout, A Elmalik, AM Azad, J Daghfal… - …, 2020 - thelancet.com
Background Hydroxychloroquine (HC) ± azithromycin (AZ) is widely used for Covid-19. The
Qatar Prospective RCT of Expediting Coronavirus Tapering (Q-PROTECT) aimed to assess …
Qatar Prospective RCT of Expediting Coronavirus Tapering (Q-PROTECT) aimed to assess …
Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19
…, MMB Ali, AM Elarabi, GAM Ali, J Daghfal… - Journal of Hospital …, 2021 - Elsevier
Background We investigated the clinical characteristics and risk factors for the isolation of
multi-drug-resistant (MDR) Gram-negative bacteria (GNB) from critically ill COVID-19 patients. …
multi-drug-resistant (MDR) Gram-negative bacteria (GNB) from critically ill COVID-19 patients. …
Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: a preliminary report
Background The role of convalescent plasma therapy for patients with coronavirus disease
2019 (COVID‐19) is unclear. Methods We retrospectively compared outcomes in a cohort of …
2019 (COVID‐19) is unclear. Methods We retrospectively compared outcomes in a cohort of …
[HTML][HTML] The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study
AS Omrani, MA Almaslamani, J Daghfal… - BMC infectious …, 2020 - Springer
Background There are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at
a national level, and none after 60 days of follow up. The aim of this study was to describe …
a national level, and none after 60 days of follow up. The aim of this study was to describe …
[HTML][HTML] Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar
…, A Ittaman, A Alimam, F Rustom, J Daghfal… - International Journal of …, 2022 - Elsevier
Objectives To estimate the real-world effectiveness of sotrovimab against severe, critical, or
fatal COVID-19 in Qatar at a time in which most SARS-CoV-2 incidences occurred due to the …
fatal COVID-19 in Qatar at a time in which most SARS-CoV-2 incidences occurred due to the …
[HTML][HTML] The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
A Zaqout, J Daghfal, I Alaqad, SAN Hussein… - International Journal of …, 2021 - Elsevier
Objective This study examined the initial impact of a national BNT162b2 vaccine rollout on
SARS-CoV-2 infections in Qatar. Methods All individuals who had completed ≥14 days of …
SARS-CoV-2 infections in Qatar. Methods All individuals who had completed ≥14 days of …
[HTML][HTML] Epidemiology, microbiological and clinical characteristics of Enterococcus species bloodstream infections: a 10-year retrospective cohort study from Qatar
…, MS Najim, KM Shunnar, SI Ibrahim, J Daghfal… - Annals of Medicine and …, 2022 - Elsevier
Background and objective Enterococcus species is one of the leading causes of community
and healthcare-associated infections resulting in significant morbidity and mortality. In this …
and healthcare-associated infections resulting in significant morbidity and mortality. In this …
[HTML][HTML] Clinical characteristics and outcomes of care in patients hospitalized with diabetic ketoacidosis
…, M Elhaj, A Ahmed, H Alqahwachi, J Daghfal… - Diabetes Research and …, 2022 - Elsevier
Aims To assess the clinical characteristics and outcomes of patients hospitalized with DKA.
Methods We examined the hospital database for patients admitted with DKA to all …
Methods We examined the hospital database for patients admitted with DKA to all …
[HTML][HTML] The role of post-bronchoscopy sputum examination in screening for active tuberculosis
…, AM Abdalhadi, M Hajmusa, J Daghfal… - Tropical Medicine and …, 2022 - mdpi.com
Early diagnosis is a fundamental component of global tuberculosis control. The objective of
this study was to evaluate the diagnostic yield of post-bronchoscopy sputum (PBS) testing as …
this study was to evaluate the diagnostic yield of post-bronchoscopy sputum (PBS) testing as …